Daniel Alkon
President at NEUROTROPE, INC.
Net worth: 6 275 $ as of 2024-04-29
Daniel Alkon active positions
| Companies | Position | Start | End |
|---|---|---|---|
| NEUROTROPE, INC. | Chief Tech/Sci/R&D Officer | 2013-08-22 | - |
| President | 2016-09-18 | - | |
| SYNAPTOGENIX, INC. | Director/Board Member | 2020-12-06 | - |
| Chief Tech/Sci/R&D Officer | - | - | |
| President | - | - |
Career history of Daniel Alkon
Former positions of Daniel Alkon
| Companies | Position | Start | End |
|---|---|---|---|
Blanchette Rockefeller Neurosciences Institute
 Blanchette Rockefeller Neurosciences Institute BiotechnologyHealth Technology Blanchette Rockefeller Neurosciences Institute provides health care solutions. The company offers to facilitate molecular signaling, which controls the functions that record our conscience experience. The company is headquartered in Morgantown, WV. | Chief Tech/Sci/R&D Officer | 1998-12-31 | 2016-09-22 |
| West Virginia University | Corporate Officer/Principal | - | 2016-08-31 |
Adaptive Systems, Inc.
 Adaptive Systems, Inc. Computer Processing HardwareElectronic Technology Adaptive Systems, Inc. manufactures and develops small, high performance modular hardware products for use by the embedded computer industry. It products include 486DX 66MHz, 586-133MHz Processors; System Management; Super I/O, VGA, PCMCIA; and Sound O/S. The company is headquartered in Longmont, CO. | Corporate Officer/Principal | - | - |
| National Institute of Neurological Disorders & Stroke | Chief Tech/Sci/R&D Officer | - | - |
Training of Daniel Alkon
| University of Pennsylvania | Undergraduate Degree |
| Cornell University | Doctorate Degree |
Statistics
International
| United States | 9 |
Operational
| Chief Tech/Sci/R&D Officer | 4 |
| President | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
| Electronic Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SYNAPTOGENIX, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Neurotrope, Inc.
 Neurotrope, Inc. Pharmaceuticals: MajorHealth Technology Neurotrope, Inc. is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. The company focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on January 11, 2011 and is headquartered in New York, NY. | Health Technology |
Adaptive Systems, Inc.
Adaptive Systems, Inc. Computer Processing HardwareElectronic Technology Adaptive Systems, Inc. manufactures and develops small, high performance modular hardware products for use by the embedded computer industry. It products include 486DX 66MHz, 586-133MHz Processors; System Management; Super I/O, VGA, PCMCIA; and Sound O/S. The company is headquartered in Longmont, CO. | Electronic Technology |
Blanchette Rockefeller Neurosciences Institute
Blanchette Rockefeller Neurosciences Institute BiotechnologyHealth Technology Blanchette Rockefeller Neurosciences Institute provides health care solutions. The company offers to facilitate molecular signaling, which controls the functions that record our conscience experience. The company is headquartered in Morgantown, WV. | Health Technology |
| National Institute of Neurological Disorders & Stroke | Government |
- Stock Market
- Insiders
- Daniel Alkon
- Experience
